Autolus Therapeutics plc (6A3A) — Working Capital to Net Assets Ratio
Autolus Therapeutics plc (6A3A) has a Working Capital to Net Assets ratio of 357.2% as of June 2026. Working capital of €267.30 Million (current assets of €336.09 Million minus current liabilities of €68.79 Million) is measured against net assets of €74.84 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See defensive interval ratio of Autolus Therapeutics plc to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Autolus Therapeutics plc Working Capital to Net Assets (2017–2025)
This chart shows how Autolus Therapeutics plc's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the ratio stands at 357.2%, reflecting working capital of €267.30 Million against net assets of €74.84 Million EUR. For the complete balance sheet picture, see Autolus Therapeutics plc asset portfolio.
Annual Working Capital to Net Assets for Autolus Therapeutics plc (2017–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Autolus Therapeutics plc from 2017 to 2025, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check 6A3A cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 203.5% | €362.48 Million | €178.13 Million | €435.92 Million | €73.44 Million | ▲ +63.0 pp |
| 2024 | 140.5% | €600.19 Million | €427.32 Million | €660.93 Million | €60.74 Million | ▼ -66.4 pp |
| 2023 | 206.8% | €230.56 Million | €111.47 Million | €275.30 Million | €44.74 Million | ▲ +79.8 pp |
| 2022 | 127.0% | €379.40 Million | €298.67 Million | €425.77 Million | €46.37 Million | ▲ +25.4 pp |
| 2021 | 101.6% | €318.40 Million | €313.32 Million | €346.95 Million | €28.55 Million | ▲ +23.8 pp |
| 2020 | 77.8% | €163.35 Million | €210.03 Million | €196.98 Million | €33.63 Million | ▼ -10.2 pp |
| 2019 | 88.0% | €224.27 Million | €254.84 Million | €249.26 Million | €24.98 Million | ▲ +5.1 pp |
| 2018 | 82.9% | €211.89 Million | €255.47 Million | €232.97 Million | €21.08 Million | ▼ -13.4 pp |
| 2017 | 96.4% | €137.45 Million | €142.60 Million | €142.48 Million | €5.03 Million | — |